Doug Monroe of Kaiser Permanente's 2015 Presentation is now available for download.
At last year's World Biosimilar Congress USA, we were excited to have Doug Monroe, Project Manager of Biotechnology, Emerging Technology, and Specialty Pharmacy at Kaiser Permanente, share his expertise on the impact of biosimilars on private reimbursement strategies.
You can now download his presentation to find out more about:
-
The Kaiser Permanente integrated health care delivery system
-
Biosimilar: planning in managed care
-
The FDA's Purple Book
-
Interchangeability
-
Switching
-
P&T issues